ScanSource, Inc.
NASDAQ:SCSCTechnology Distributors
+$0.51 today
- Market cap
- $903.45M
- Beta
- 1.31
- P/E (TTM)
- 14.3
- EPS (TTM)
- $3.44
Volume 0.28M
Average 0.23M
SCSC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
ScanSource, Inc.NASDAQ: SCSC
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
| FY2021 | 2021-06-30 | 0 | — |
Research & Development vs competitors
How SCSC compares with its peers on the latest reported figures
- SCSC's LTM Mar 2026 research & development of $0 is the highest of the 6 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for SCSC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
CLMBClimb Global Solutions, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding SCSC) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for SCSC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 3.15B | 3.53B | 3.79B | 3.26B | 3.04B |
| Cost of Revenue | 2.8B | 3.1B | 3.34B | 2.86B | 2.63B |
| Gross Profit | 350.72M | 426.52M | 449.24M | 399.05M | 408.65M |
| Gross Margin | 11.1% | 12.1% | 11.9% | 12.2% | 13.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 275.44M | 0 | 277.43M | 286.93M |
| Operating Expenses | 289.23M | 304.36M | 313.35M | 308.73M | 323.45M |
| Depreciation & Amortization | 33.51M | 29.92M | 28.61M | 28.01M | 30.2M |
| EBITDA | 104.76M | 155.06M | 170.25M | 140.88M | 132.6M |
| EBITDA Margin | 3.3% | 4.4% | 4.5% | 4.3% | 4.4% |
| Operating Income | 61.48M | 122.17M | 135.89M | 90.32M | 85.2M |
| Operating Margin | 2.0% | 3.5% | 3.6% | 2.8% | 2.8% |
| Interest Income | 3.1M | 4.33M | 7.41M | 9.38M | 11.25M |
| Interest Expense | 6.93M | 6.52M | 19.79M | 13.03M | 8.01M |
| Other Income / Expenses | (3.95M) | (3.54M) | (14.04M) | 9.52M | 9.2M |
| Income Before Tax | 57.54M | 118.62M | 121.85M | 99.84M | 94.4M |
| Pre-Tax Margin | 1.8% | 3.4% | 3.2% | 3.1% | 3.1% |
| Income Tax Expense | 12.15M | 29.93M | 33.76M | 22.78M | 22.85M |
| Net Income | 10.8M | 88.8M | 89.81M | 77.06M | 71.55M |
| Net Margin | 0.3% | 2.5% | 2.4% | 2.4% | 2.4% |
| EPS (Basic) | 1.79 | 3.48 | 3.50 | 3.10 | 3.05 |
| EPS (Diluted) | 1.78 | 3.44 | 3.47 | 3.06 | 3.00 |
| Weighted Avg Shares | 25.42M | 25.5M | 25.14M | 24.87M | 23.44M |
| Weighted Avg Shares (Diluted) | 25.52M | 25.76M | 25.36M | 25.22M | 23.84M |
ScanSource, Inc.
NASDAQ:SCSC
Intrinsic Alpha fair value
Locked
Current Price
$44.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.